Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.41
-0.69 (-7.58%)
Mar 6, 2026, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $563.27 million as of March 6, 2026. Its market cap has decreased by -13.40% in one year.
Market Cap
563.27M
Enterprise Value
823.38M
1-Year Change
-13.40%
Ranking
Category
Stock Price
$8.41
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $563.27M, a decrease of -21.05%. That is a compound annual growth rate of -4.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 563.27M | 13.04% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 671.14M |
| Tactile Systems Technology | 646.47M |
| Avanos Medical | 618.03M |
| SI-BONE | 610.81M |
| Perspective Therapeutics | 566.15M |
| Cytek Biosciences | 542.48M |
| BrainsWay | 510.81M |
| Orthofix Medical | 506.62M |